Next Article in Journal
Double-Network Tough Hydrogels: A Brief Review on Achievements and Challenges
Previous Article in Journal
Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Gels
Volume 8
Issue 4
10.3390/gels8040246
gels-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Graphene Oxide-Reinforced Alginate Hydrogel for Controlled Release of Local Anesthetics: Synthesis, Characterization, and Release Studies

by
Cuong Hung Luu
1,
Giang Nguyen
1,
Thanh-Tuyen Le
1,
Thanh-Mai Ngoc Nguyen
1,
V. H. Giang Phan
1,
Mohanapriya Murugesan
2,
Ramya Mathiyalagan
2,
Lu Jing
3,
Gopinathan Janarthanan
4,
Deok Chun Yang
2,
Yi Li
5,* and
Thavasyappan Thambi
6,*
1
Biomaterials and Nanotechnology Research Group, Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City 70000, Vietnam
2
Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin si 17104, Korea
3
Division of General Education, Seokyeong University, Seoul 02173, Korea
4
Research and Development Department, ECOWORLD Pharm Co., Ltd., Damyang-gun 57304, Korea
5
College of Materials and Textile Engineering, Nanotechnology Research Institute, Jiaxing University, Jiaxing 314001, China
6
School of Chemical Engineering, Sungkyunkwan University, Suwon 16419, Korea
*
Authors to whom correspondence should be addressed.
Gels 2022, 8(4), 246; https://doi.org/10.3390/gels8040246
Submission received: 11 March 2022 / Revised: 13 April 2022 / Accepted: 14 April 2022 / Published: 16 April 2022
Browse Figures
Versions Notes

Abstract

:
In pain relief, lidocaine has gained more attention as a local anesthetic. However, there are several side effects that limit the use of local anesthetics. Therefore, it is hypothesized that a hydrogel system with facile design can be used for prolonged release of lidocaine. In this study, we developed a formulation comprises of sodium alginate (SA) and graphene oxide (GO) to prolong the release of lidocaine. The gelation was induced by physically crosslinking the alginate with Ca2+ ions. The formation of blank SA and GO-reinforced SA hydrogels was investigated with different concentration of Ca2+ ions. The controlled release of lidocaine hydrochloride (LH) on both hydrogel systems was studied in PBS solution. The GO-reinforced SA hydrogels exhibited more sustained release than SA hydrogels without GO. In vitro biocompatibility test in L929 fibroblast cells confirmed the non-toxic property of hydrogels. Furthermore, to prove the in-situ gelation and biodegradability of hydrogels the hydrogels were injected on mice model and confirmed the stable gel formation. The hydrogels implanted onto the subcutaneous tissue of hydrogels retained over one week. These results indicate that LH-loaded GO-reinforced SA hydrogel can be a potential biomaterial for controlled release of local anesthetics.

1. Introduction

It is inevitable that patients who underwent operation suffer from chronic post-surgical pain. Such pain can result in local physical trauma and even emotional drowsiness, which can lead to dysfunctional behaviors in social life [1,2,3]. Therefore, there is the thriving need for preventing and relieving undesirable complications. Peripheral use of local anesthetics (lidocaine, bupivacaine, procaine, dibucaine, etc.) are commonly exploited for analgesia through a single administration [4,5]. These medicines initiate the excitation and conduction processes that consequently prohibit the transmission of nerve impulses, thereby numbing a specific administered site [6]. Lidocaine, which is usually used in the form of hydrochloride salt, is an amide based local anesthetic. Typical properties of lidocaine are low molecular weight and highly lipophilic [7]. These factors favorably influence local anesthetic activity, resulting in great penetration through the nerve membrane, high degree of protein binding, rapid onset and long action time [8,9]. Clinically, due to the ideal pKa of 7.9 and aqueous solubility, the ionized form of lidocaine is preferred and become the most prevalent local anesthetics [10].
Although the safety of local anesthetics is higher than that of general anesthetics, its clinical application is greatly limited by various side effects. Some of those issues are neurotoxicity and sharp fluctuating levels of plasma-drug concentration [11,12]. Moreover, sustaining administration of local anesthetic is challenging to carry out, which leads to weak compliance [12,13]. In addition, lidocaine could trigger numerous adverse effects, such as vasodilation, serious arrhythmias, and depleted peripheral resistance [14,15,16]. Therefore, versatile drug delivery systems have been engineered to facilitate prolongation of lidocaine release locally at the treatment site and lessen toxicity. Hydrogels are of great concern in acute and chronic pain management owing to their biocompatibility and their ability to control encapsulated therapeutic agents [8,17,18,19,20,21,22,23,24,25]. Although there have been diverse polymer-based hydrogel systems were investigated, sodium alginate (SA) has been gaining an intense interest. SA is a linear polysaccharide derivative of alginic acid composed of (1–4)-linked β-D-mannuronic (M) and α-L-guluronic (G) acids. It possesses prominent characteristics, including high adsorption capacity, cytocompatibility, non-immunogenicity and natural abundance [13,26,27]. In addition, SA is identified by the abundant anionic carboxylate groups distributed along the backbone chain which can interact with positively charged groups of drugs to generate ionic complexes and control sustaining release [28,29,30]. In case of lidocaine delivery, SA is adopted as the most appropriate material. However, uncontrolled degradation properties of SA hydrogels induce the rapid lidocaine release and therefore requires frequent injection.
In order to improve the stability and control degradation of hydrogel network system, graphene oxide (GO) was introduced to the hydrogel network [31]. Apart from graphite, GO is a mono-layer and oxidized derivate of it, which is overexpressed with plentiful oxygen-enriched functionalities on graphene-based planar sheets, thus making it have high solubility in water as well as organic solvents [29,32]. Furthermore, the oxygenated groups, especially hydroxyls and carboxylic acids, can further formulate the ionic complexes with the basic groups of lidocaine hydrochloride (LH) [33,34]. Altogether, GO was considered as the best promising combination for any conventional hydrogel system.
In this study, we developed injectable hydrogel system using GO-reinforced SA (GO-SA) hydrogel system for the controlled release of LH (Scheme 1). The harmonious association of LH with GO-SA hydrogels, verified by macroscopic observation and microscopic analysis. The physicochemical properties of hydrogels were assessed by using Fourier-transformed infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), ionic complexation and degradation studies, while the morphological and geometrical properties were analyzed by scanning electron microscopy (SEM). Drug loading capacity and release profile of LH were conducted to set a comparison between GO-SA and GO-free SA hydrogel systems in order to clarify the aid of GO in the drug interaction rate. In vitro biocompatibility of GO-SA and GO-free SA hydrogels were confirmed by co-culturing them with L929 fibroblast cells. In addition, in vivo degradation of the hydrogel systems was examined to further consolidate the suitable use of GO.

2. Results and Discussion

2.1. Characterization of GO

Thanks to π-conjugating carbon-based network, graphite as well as graphene hardly exhibit the difference in the state of charges within their chemical structure, leading to a minimal dipole moment [35]. However, pristine graphite powder undertaken the oxidative process exposed various vibration signals, corresponding to the introduction of oxygenated functional groups on the basal plane of graphene, which indicates the successful treatment. In general, all FT-IR spectra in Figure 1A reveal the similar pattern of vibrations. It is clear that all GO samples were effectively fabricated by the modified Hummer method. In which, the strong trough at approximately 3455 cm–1 are contributed to the O-H stretching containing in hydroxyl and carboxylic acid. The nominal signals at under 3000 cm–1 are supposed to be the stretch mode of the sp2 and sp3 hybridizations of carbon skeletal network (C–C, C=C). The sharp bands at 1638 cm–1 correlate to the stretching vibration of the carbonyl group (C=O). The overlapped troughs at the wavenumbers of 1140 and 1082 cm–1 also indicate the C–O–C and C–CO–C stretching signals, containing in carboxyl and epoxy groups. It is widely evident that GO is functionalized by plentiful oxygen-enriched groups, such as carboxyl, hydroxyl, carbonyl and epoxy groups, as presented in our spectra [36,37,38].
Figure 1B shows the TGA plot of GO2, GO4, GO6 compared to graphite powder. It can be seen that, graphite specimen remains great stability and endurance under high temperature, a bit of weight gaining can be explained by the adsorption of nitrogen gas onto its surface. Notwithstanding the great stability of graphite, GO exhibits the low maintenance under the effect of temperature. The novel volatile functionalities introduced to graphene network have eased the decomposition of GO, resulting in the releases of CO2, H2O and other small molecules, which contributed to the mass losses [39,40]. Relatively, the weight loss of GO6 is two-fold higher than that of GO2, whereas the absorbance of the band at 3455 cm–1 of GO6 is just over 2.5 times higher than that of GO2. For this reason, it could be considered that the higher level of oxidative agent leads to the more oxygenated groups functionalized in GO specimen.
As mentioned, SEM analysis was used as a method to observe the morphology of GO. The analyzed sample was be prepared by dispersing GO6 powder into deionized water, of which dropped on aluminum foil to randomly take SEM images. Figure 1C reveals that the GO flakes expose a folded and thin-layered shape at a monoatomic thickness, which approves the successful exfoliation process in GO synthesis. Furthermore, those layers are likely to closely associate with each other due to their electrostatic interactions via the surficial functionalities, thereby expressing an aggregated form comprised of individual sheets and also space apart in some places (Figure 1D).
Solubility of GOs is a prerequisite for this research. Therefore, the suspension of GOs in deionized water was evaluated to select the most suitable sample. According to Figure 2A, the graphite sample shows that there is black scum covered on the surface of the suspension, which is also less common in GO2 and GO4 samples. It is explained that the inherent hydrophobicity of graphene plates which dominants the amphiphilicity of GO2 and GO4, driving them high surface tension to diffuse in aqueous medium. On the other hand, the GO6 sample exhibits a good dispersibility after 12 h, that could be considered as the most appropriate sample for upcoming experiments. More importantly, presence of surfactants and NaCl in the dispersion medium not affected the dispersibility of GO6 (Figure 2B).
Figure 2C affirms the interaction of LH and GO by means of ionic complexation. It is clear that the LH10 solution remains apparent throughout the experiment. As just mentioned, the GO (LH0/GO) solution still reveals the well-dispersed property by day 4. Meanwhile, the LH-containing solutions (LH5/GO, LH10/GO) are less turbid than LH-free solution (LH0/GO) and show a significant aggregation on day 4. The phenomenon showed that there was a surface charge transition of GO from very negative to neutral. The neutralization, which mostly causes by the complexation between the basic group of LH and the acidic carboxyl of GO, induces GO plates to cluster together into a mass and conglomerate at the bottom.

2.2. Characterization of SA and GO-SA Hydrogels

Theoretically, in order to develop a hydrogel network, it is necessary to have an appropriate amount of crosslinking agent to determine the three-dimensional structure. Therefore, a series of CaCl2 solutions at multiple concentrations were used to examine gelation ability of this crosslinking agent. As a result, Table 1 indicates the gelation time of GO-free and GO-SA hydrogels in the presence of increasing concentration of Ca2+ ions. In particular, the concentrations below 0.4 mol/L cannot form hydrogel (Figure 3A). For higher amounts of crosslinker, the gelation time diminishes consistently with the increase of Ca2+ concentration, which was extensively reported in previous publications [41,42]. Moreover, the association of GO in the SA matrix also reveals short gelation time as compared to GO-free hydrogel. It could be explained that GO sheets offer synergetic effects to the GO-SA hydrogel formation by promoting diverse types of interactions: hydrogen bonds between oxygen-containing groups of GO plates and SA chains, divalent cation interactions of Ca2+ ions with GO plates and conventional divalent cation interaction generating hydrogel structure [43]. However, clinical practice shows that the gelation time at the crosslinker concentration of 0.06 mol/L is favorable to form hydrogel inside living body. Hence, this formulation was chosen to utilize in the in vivo experiment.
SEM analysis was also used to provide intuitive information in terms of interfacial morphology and crosslinking interaction of composite systems. As shown in Figure 3B, the pristine calcium alginate reveals a smooth surface, while Figure 3C is saliently witnessed convex and banded texture exposing on the surface of calcium alginate network. The embedded GO might be attributed to the distinction in morphological properties. Both composite matrices show porous architecture. However, the inner structure of GO-SA hydrogel is relatively denser than that of pure SA hydrogel since the aforementioned reasons, which contemplates the augmentation in tensile strength and stability of the hydrogel.

2.3. Degradation of SA and GO-SA Hydrogels

By observing the macroscopic morphology of hydrogel samples in PBS medium (Figure 4), it is recognized that the GO0/SA present rapid swelling at the interfacial surface. After 2 weeks, the hydrogel mostly decayed into an opaque liquid which contains decomposed SA polymer chains. This quick decay might be contributed by the ion exchange between divalent ions (Ca2+) in calcium alginate and monovalent ions existing in PBS solution [44]. For GO-SA hydrogels, there is a more stable tendency in the aqueous medium. Indeed, the higher concentration of GO boosts the synergetic effects of GO on the reinforcement of hydrogel, thereby lessening the degradation of the hydrogel systems under fluid condition [43,45].

2.4. In Vitro Drug Release

SA and GO-SA hydrogels were used to encapsulate the model anesthetic (LH), in which the soluble form of lidocaine, lidocaine hydrochloride, was released in PBS medium with time. The behavior of release profiles, which illustrates in Figure 5, is considered to be relatively linear and stable without burst release. The higher slope in the release of SA hydrogel reveals the faster drug release rate compared with that of GO-SA hydrogel. After 120 h, 62.73 ± 0.70% encapsulated drug had diffused out of SA hydrogel network into external medium, whereas there was only 51.10 ± 0.44% LH had been released from GO-SA hydrogel. It is persuasive that our facile design of graphene oxide-incorporated polymeric hydrogel is efficient to delivery and control sustaining release of lidocaine for local anesthesia.

2.5. In Vitro Biocompatibility of Hydrogels

Non-toxic property of hydrogels or hydrogelators is an essential factor for biomaterials in in vivo applications. In order to prove biocompatibility of hydrogels, various concentrations of SA or GO-SA hydrogels were co-incubated with L929 mouse fibroblast cells for 48 h followed by evaluating the viability using MTT assay. The cell viability of L929 mouse fibroblast cells co-cultured with hydrogels is shown in Figure 6. As expected, cell viability of fibroblast cells was high (>80%) even they were exposed with 2000 µg/mL of hydrogel precursors, which implied the biocompatibility of GO-SA hydrogels.

2.6. In Vivo Hydrogel Formation

The in vivo study has fully confirmed the utility of the GO-SA hydrogel system, as shown in Figure 7. After subcutaneous administration, the gel has been successfully implanted at specific site of mice, which demonstrates an appropriate gelation time to be used as an injectable hydrogel system. After injection, the mice have normal function and no abnormal behavior within 1 week. When dissected, the hydrogel showed sign of degradation, while internal organs surrounding the gels were not infected or inflamed. It is clear that the GO-integrated SA hydrogel can be used as a local anesthetic delivery system.
In the GO-SA hydrogel system, the in vivo formation mainly underlies the physical-crosslinking of Ca2+ ions and a pair of buckled α-L-guluronic acid (G) residues. This combination induced a rapid gel formation. Furthermore, with the use of GO, there could be other kinds of physical crosslinks, such as hydrogen bonding between oxygen-containing groups of GO plates and SA chains and divalent cation interactions of Ca2+ ions with GO plates, appearing in the hydrogel.

3. Conclusions

Our study aims to design a facile hydrogel system from SA, and use synthetic GO for controlled release of lidocaine. Herein, the GO is successfully fabricated by the modified Hummer method without extra oxidative agents. The chemical structure and oxidation level of GO are confirmed by FT-IR and TGA. GO6 with the highest oxidation level reveals good solubility and dispersity in aqueous medium. Furthermore, the ionic complexation of GO and LH constitutes a key factor to enhance the loading capacity and controlled release for the hydrogel system. The result showed that the blending of 4% SA solution and 0.06 mol/L CaCl2 solution gives the most appropriate result due to the suitable gelation time. The incorporation of 0.5% GO in SA matrix shows the quicker gelation time as well as good stability and release behavior of LH. Furthermore, the in vivo study on mice also yields a positive result with high compatibility and degradation, which shows that the LH-loaded GO-SA hydrogel can be a successful drug delivery system for controlled release.

4. Materials and Methods

4.1. Materials

Graphite powder, concentrated sulfuric acid (H2SO4, 95–98%), and potassium permanganate (KMnO4, 99%) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Alginic acid sodium salt (SA), phosphate buffered saline pH 7.4 (PBS) and anhydrous calcium chloride (CaCl2, 98%) was provided by Merck (Darmstadt, Germany). Hydrogen peroxide (H2O2, ~30%), concentrated hydrochloride (HCl, 37%) and lidocaine hydrochloride monohydrate (LH, 98%) were purchased from Fisher Chemicals (Trenton, NJ, USA).

4.2. Methods

Morphological properties of GO and hydrogels were observed by scanning electron microscope (SEM, JSM-IT100, Tokyo, Japan). The introduction of oxygen-containing groups of GO was detected by Fourier-transformed infrared spectrophotometer (FT-IR, PerkinElmer, Waltham, MA, USA) using KBr pellet method. Thermogravimetric analysis (TGA, Mettler Toledo TGA/DSC 3+, Sweden) was carried out to investigate thermal stability of GO, and to preliminarily examine the oxidative level the samples. The TGA plot was recorded from 30 to 700 °C at the ramping rate of 10 °C·min–1 under the continuous flow of N2 gas. All resultant data were illustrated as mean ± standard deviations.

4.3. Syntheses of GOs

The synthesis of GO in this study was attempted on the basis of Hummers method with minimal modification [46,47]. Our approach is considered to be NaNO3-free methods, advancing the low consumption of reagent but remaining the high yield, in which we utilized sulfuric acid as an intercalator and acidic oxidizing medium, KMnO4 as a strong oxidative agent, water and hydrogen peroxide as exfoliators [48,49]. In brief, three suspensions of 0.8 g graphite powder in 15 mL of concentrated H2SO4 were prepared, stirring at 0 °C for 1 h. Particular levels of oxidative agent (2, 4, 6 g) were gradually dissolved into the solutions, the reactions were carried out for 3 h. Based on the oxidative agents the samples were denoted as GO2, GO4, GO6. Sequentially, the mixture was placed at 35 °C, stirring for 2 h. In order to gain separate GO lattices, 60 mL of deionized water (DIW) and 6 mL of H2O2 (30%) were, respectively, added and remained the same conditions for 1 h. Ultimately, 150 mL DIW was used to propagate the syntheses of GOs. The resultant mixtures were rinsed by HCl 5% solution and centrifuged in the first place. Then precipitates were rinsed again with distilled water and centrifuged until the pH reached neutral. The precipitates were lyophilized for further use.

4.4. Preparation of GO and LH Ionic Complexes

After the preparation of GOs, dispersibility test is convincing to select the most suitable GO for the drug delivery system. This kind of GO must attain a high solubility and sustaining suspension in aqueous medium. Three samples of GOs were dissolved in distilled water and put in an ultrasonic bath for 30 min. Those well-dispersed samples were all placed stable conditions for 12 h and observed. As hypothesized, the ionic complexes between GO and LH might be developed due to the opposite charges, of which interaction might generate a significant change in electric charge of multivalent GO. Therefore, we demonstrated it by preparing and observing four dispersions that had the final concentrations of GO at 0.25 mg/mL and LH at 0, 5, 10 mg/mL, which were expressed as LH0/GO, LH5/GO, LH10/GO, respectively, and a solution of LH (10 mg/mL), which was expressed as LH10.

4.5. Fabrication of SA and GO-SA Hydrogels

The sodium alginate hydrogel systems could be formulated by versatile crosslinking agents, either chemical or physical [50,51]. In order to simplify the fabrication, we decided to elect calcium ion (Ca2+) as a physical crosslinker using the CaCl2 source. In this experiment, GO-free SA and GO-SA hydrogels formation were prepared by a series of CaCl2 concentrations, as designated by SA and GO-SA hydrogels, respectively. GO-SA suspension was prepared by mixing 8% SA solution with 0.5% GO6 dispersion in DIW (w/v). Then, both mixtures were sonicated in an ultrasonic bath for 30 min to yield the SA and GO-SA solutions. A set of seven aqueous solutions of CaCl2 was prepared by diluting from the concentration of 0.07 to 0.01 mol/L at intervals of 0.01 mol/L. In order to fabricate the hydrogels, 1 mL crosslinker solution at various concentrations was blended with 1 mL polymer solution, the mixture was gently shaken to be well-mixed and contemporaneously record gelation time of each combination using a stopwatch.

4.6. Degradation Study of SA and GO-SA Hydrogels

Notwithstanding universal applications of pure alginate hydrogel in biomedical field, the lack of mechanical strength and inevitable swelling in solution have exposed as remarkable limits in some specific approaches [52]. In addition to the potential in improved adsorption capacity, GO was widely known that can effectively integrate with polymeric matrix, particularly alginate, to reinforce the hydrogel network and complement the structural and mechanical properties of it [53,54]. In order to evaluate the stability of SA and GO-SA hydrogels, the degradation experiment was utilized. Briefly, GO6 (0.125%, 0.25%, 0.5% w/v), SA (8% w/v), LH (2% w/v) and CaCl2 (0.06 mol/L) stock solutions were prepared with deionized water (Table 2). Equivalent volume of above solutions was mixed to develop hydrogels, and those specimens was compared with a GO-free hydrogel. After complete gelation, the specimens were placed in 3 mL of PBS solution to further observe.

4.7. Loading and In Vitro Release of LH

In order to testify the controlled release effect of GO towards SA hydrogel system, the model analgesic drug (lidocaine hydrochloride) was loaded into the GO-SA hydrogel and blank hydrogel (without GO). Before complete blending of individual component solutions, the 2% LH solution (w/v) and 0.5% GO6 solution (w/v) were mixed at the proportionate ratio and stirred for 1 h. Gelation of GO-SA hydrogel was conducted as previously aforementioned, in which the drug solution, SA (8% w/v) and CaCl2 (0.06 mol/L) solutions were combined at the ratio of 2:1:1, respectively. For the GO-free SA hydrogel, the GO6 solution was replaced by deionized water. After accomplishing gelation, the hydrogels were slightly immersed in 3 mL PBS solution and placed at body temperature (37 °C). At regular time intervals of a day, 1.5 mL release solution of sample aliquots was pipetted out and stored for analysis. An equivalent volume of medium was refilled and kept maintain the previous condition. Eventually, the amount of LH in the collected sample aliquots was measured by UV-Vis spectrophotometer at the wavelength of 265 nm, whereas PBS was utilized as the reference standards. This experiment was carried out in triplicate.

4.8. In Vitro Cytotoxicity

The L929 cells were purchased from Korean Cell Line Bank (KCLB) and cultured in a DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (1%, (w/v)). Subsequently, the cell flasks were incubated at 37 °C in a humidified 5% CO2˗95% air atmosphere. To confirm the biocompatibility, the cells were cultured with various concentrations of copolymers. After 48 h, 20 µL MTT solution (from 5 mg/mL stock solution) was added and incubated for 3 h at 37 °C. At the same time, the purple crystals were dissolved in DMSO and the viability was examined with Microplate reader by measuring the absorbance at 490 nm. The L929 cells cultured with only fresh culture medium were used as control.

4.9. In Vivo Hydrogel Formation and Compatibility

This study aims to assess the in vivo hydrogel formation and compatibility of hydrogel system on animal model. The animal experiments performed in this work were approved by the Institutional Committees of Jiaxing University and the animal experiments were conducted according to the guidelines of Jiaxing University. Mice (BALB/c mice, 20.0 ± 2.0 g) were used to carry out the experiment. The mice were anesthetized by introducing 5% of isoflurane in oxygen via a vaporizer. Separate blends of GO-SA mixture including LH (0.5% w/v) and crosslinker solution were prepared. Then, the blends of GO/SA and CaCl2 were placed in the dual syringe before the injection [55,56]. Then the mixture was injected subcutaneously. After 30 min, a mouse was sacrificed for gel observation. The status of hydrogel formation was observed to demonstrate injectable capability. After 1 week, the mice were also sacrificed and the compatibility of the hydrogel system was assessed.

Author Contributions

C.H.L.: conceptualization, methodology, project execution, validation, formal analysis, investigation, visualization. G.N.: methodology, writing—review and editing, visualization. T.-T.L.: writing—review and editing. T.-M.N.N.: methodology, writing—review and editing. V.H.G.P.: writing—review and editing. M.M.: formal analysis, writing—review and editing. R.M.: visualization. L.J.: visualization and funding acquisition. G.J.: writing—review and editing. D.C.Y.: visualization. Y.L.: editing, visualization and funding acquisition. T.T.: conceptualization, methodology, validation, writing—review and editing, Supervision, and Project administration. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (NSFC) (No. 81901900), Zhejiang Provincial Natural Science Foundation (LY22E030012), and Public Welfare Project of Jiaxing Municipal Bureau of Science and Technology (2021AY10056). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant no: NRF- 2020R1I1A1A01070867, R.M.).

Institutional Review Board Statement

The animal experiments performed in this work were approved by the Institutional Committees of Jiaxing University and the animal experiments were conducted according to the guidelines of Jiaxing University.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bhusal, P.; Harrison, J.; Sharma, M.; Jones, D.S.; Hill, A.G.; Svirskis, D. Controlled release drug delivery systems to improve post-operative pharmacotherapy. Drug Deliv. Transl. Res. 2016, 6, 441–451. [Google Scholar] [CrossRef] [PubMed]
  2. Dowell, D.; Haegerich, T.M.; Chou, R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA 2016, 315, 1624–1645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Gordon, D.B.; de Leon-Casasola, O.A.; Wu, C.L.; Sluka, K.A.; Brennan, T.J.; Chou, R. Research Gaps in Practice Guidelines for Acute Postoperative Pain Management in Adults: Findings From a Review of the Evidence for an American Pain Society Clinical Practice Guideline. J. Pain 2016, 17, 158–166. [Google Scholar] [CrossRef] [PubMed]
  4. Li, Y.; Zhao, E.; Li, L.; Bai, L.; Zhang, W. Facile design of lidocaine-loaded polymeric hydrogel to persuade effects of local anesthesia drug delivery system: Complete in vitro and in vivo toxicity analyses. Drug Deliv. 2021, 28, 1080–1092. [Google Scholar] [CrossRef] [PubMed]
  5. Santamaria, C.M.; Woodruff, A.; Yang, R.; Kohane, D.S. Drug delivery systems for prolonged duration local anesthesia. Mater. Today 2017, 20, 22–31. [Google Scholar] [CrossRef]
  6. Becker, D.E.; Reed, K.L.J.A.p. Local anesthetics: Review of pharmacological considerations. Anesth. Prog. 2012, 59, 90–102. [Google Scholar] [CrossRef] [Green Version]
  7. Muniz, B.V.; Baratelli, D.; Di Carla, S.; Serpe, L.; da Silva, C.B.; Guilherme, V.A.; Ribeiro, L.N.d.M.; Cereda, C.M.S.; de Paula, E.; Volpato, M.C.; et al. Hybrid Hydrogel Composed of Polymeric Nanocapsules Co-Loading Lidocaine and Prilocaine for Topical Intraoral Anesthesia. Sci. Rep. 2018, 8, 17972. [Google Scholar] [CrossRef]
  8. Wang, B.; Wang, S.; Zhang, Q.; Deng, Y.; Li, X.; Peng, L.; Zuo, X.; Piao, M.; Kuang, X.; Sheng, S.; et al. Recent advances in polymer-based drug delivery systems for local anesthetics. Acta Biomater. 2019, 96, 55–67. [Google Scholar] [CrossRef]
  9. Welin-Berger, K.; Neelissen, J.A.; Engblom, J. Physicochemical interaction of local anesthetics with lipid model systems--correlation with in vitro permeation and in vivo efficacy. J. Control. Release Off. J. Control. Release Soc. 2002, 81, 33–43. [Google Scholar] [CrossRef]
  10. Kevadiya, B.D.; Joshi, G.V.; Mody, H.M.; Bajaj, H.C. Biopolymer–clay hydrogel composites as drug carrier: Host–guest intercalation and in vitro release study of lidocaine hydrochloride. Appl. Clay Sci. 2011, 52, 364–367. [Google Scholar] [CrossRef]
  11. Møiniche, S.; Mikkelsen, S.; Wetterslev, J.; Dahl, J.B. A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br. J. Anaesth. 1998, 81, 377–383. [Google Scholar] [CrossRef] [PubMed]
  12. Swain, A.; Nag, D.S.; Sahu, S.; Samaddar, D.P. Adjuvants to local anesthetics: Current understanding and future trends. World J. Clin. Cases 2017, 5, 307–323. [Google Scholar] [CrossRef] [PubMed]
  13. Sanchez, M.F.; Guzman, M.L.; Apas, A.L.; Alovero, F.d.L.; Olivera, M.E. Sustained dual release of ciprofloxacin and lidocaine from ionic exchange responding film based on alginate and hyaluronate for wound healing. Eur. J. Pharm. Sci. 2021, 161, 105789. [Google Scholar] [CrossRef] [PubMed]
  14. Li, Y.; Zhao, E.; Li, L.; Bai, L.; Zhang, W. Physicochemical and pharmacological investigations of polyvinylpyrrolidone—tetrahydroxyborate hydrogel containing the local anesthetic lidocaine. J. Mol. Liq. 2021, 335, 116526. [Google Scholar] [CrossRef]
  15. Williams, C.J.A.; Alstrup, A.K.O.; Bertelsen, M.F.; Jensen, H.M.; Leite, C.A.C.; Wang, T. When local anesthesia becomes universal: Pronounced systemic effects of subcutaneous lidocaine in bullfrogs (Lithobates catesbeianus). Comp. Biochem. Physiol. Part A Mol. Integr. Physiol. 2017, 209, 41–46. [Google Scholar] [CrossRef] [PubMed]
  16. Yu, X.; Wang, J.; Huang, L.; Yu, X.; He, Z. Efficacy and Safety of Bupivacaine versus Lidocaine in Local Anesthesia of the Nasopharynx: A Meta-analysis. Am. J. Rhinol. Allergy 2016, 30, e176–e180. [Google Scholar] [CrossRef] [PubMed]
  17. Ahmed, E.M. Hydrogel: Preparation, characterization, and applications: A review. J. Adv. Res. 2015, 6, 105–121. [Google Scholar] [CrossRef] [Green Version]
  18. Giang Phan, V.H.; Duong, H.T.T.; Thambi, T.; Nguyen, T.L.; Turabee, M.H.; Yin, Y.; Kim, S.H.; Kim, J.; Jeong, J.H.; Lee, D.S. Modularly engineered injectable hybrid hydrogels based on protein-polymer network as potent immunologic adjuvant in vivo. Biomaterials 2019, 195, 100–110. [Google Scholar] [CrossRef]
  19. Thambi, T.; Giang Phan, V.H.; Kim, S.H.; Duy Le, T.M.; Duong, H.T.T.; Lee, D.S. Smart injectable biogels based on hyaluronic acid bioconjugates finely substituted with poly(β-amino ester urethane) for cancer therapy. Biomater. Sci. 2019, 7, 5424–5437. [Google Scholar] [CrossRef]
  20. Thambi, T.; Li, Y.; Lee, D.S. Injectable hydrogels for sustained release of therapeutic agents. J. Control. Release 2017, 267, 57–66. [Google Scholar] [CrossRef]
  21. Thambi, T.; Giang Phan, V.H.; Lee, D.S. Stimuli-Sensitive Injectable Hydrogels Based on Polysaccharides and Their Biomedical Applications. Macromol. Rapid Commun. 2016, 37, 1881–1896. [Google Scholar] [CrossRef] [PubMed]
  22. Kim, S.H.; Thambi, T.; Lym, J.S.; Giang Phan, V.H.; Lee, D.S. Tunable Engineering of Heparinized Injectable Hydrogels for Affinity-Based Sustained Delivery of Bioactive Factors. Macromol. Mater. Eng. 2019, 304, 1900279. [Google Scholar] [CrossRef]
  23. Jung, J.M.; Kim, S.H.; Giang Phan, V.H.; Thambi, T.; Lee, D.S. Therapeutic effects of boronate ester cross-linked injectable hydrogels for the treatment of hepatocellular carcinoma. Biomater. Sci. 2021, 9, 7275–7286. [Google Scholar] [CrossRef]
  24. Kamaci, M.; Kaya, I. Melamine-based poly(azomethine) hydrogels: Mechanical, biodegradability, drug loading and antibacterial properties. Eur. Polym. J. 2018, 108, 107–115. [Google Scholar] [CrossRef]
  25. Kamaci, M.; Kaya, İ. Biodegradable and antibacterial poly(azomethine-urethane)-chitosan hydrogels for potential drug delivery application. Polym. Adv. Technol. 2020, 31, 898–908. [Google Scholar] [CrossRef]
  26. Martău, G.A.; Mihai, M.; Vodnar, D.C. The Use of Chitosan, Alginate, and Pectin in the Biomedical and Food Sector-Biocompatibility, Bioadhesiveness, and Biodegradability. Polymers 2019, 11, 1837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Sikareepaisan, P.; Ruktanonchai, U.; Supaphol, P. Preparation and characterization of asiaticoside-loaded alginate films and their potential for use as effectual wound dressings. Carbohydr. Polym. 2011, 83, 1457–1469. [Google Scholar] [CrossRef]
  28. Madsen, M.; Westh, P.; Khan, S.; Ipsen, R.; Almdal, K.; Aachmann, F.L.; Svensson, B. Impact of Alginate Mannuronic-Guluronic Acid Contents and pH on Protein Binding Capacity and Complex Size. Biomacromolecules 2021, 22, 649–660. [Google Scholar] [CrossRef] [PubMed]
  29. Papageorgiou, S.K.; Kouvelos, E.P.; Favvas, E.P.; Sapalidis, A.A.; Romanos, G.E.; Katsaros, F.K. Metal–carboxylate interactions in metal–alginate complexes studied with FTIR spectroscopy. Carbohydr. Res. 2010, 345, 469–473. [Google Scholar] [CrossRef]
  30. Kim, S.H.; Thambi, T.; Giang Phan, V.H.; Lee, D.S. Modularly engineered alginate bioconjugate hydrogel as biocompatible injectable scaffold for in situ biomineralization. Carbohydr. Polym. 2020, 233, 115832. [Google Scholar] [CrossRef]
  31. Noh, M.; Kim, S.-H.; Kim, J.; Lee, J.-R.; Jeong, G.-J.; Yoon, J.-K.; Kang, S.; Bhang, S.H.; Yoon, H.H.; Lee, J.-C.; et al. Graphene oxide reinforced hydrogels for osteogenic differentiation of human adipose-derived stem cells. RSC Adv. 2017, 7, 20779–20788. [Google Scholar] [CrossRef] [Green Version]
  32. Paulista Neto, A.J.; Fileti, E.E. Elucidating the amphiphilic character of graphene oxide. Phys. Chem. Chem. Phys. 2018, 20, 9507–9515. [Google Scholar] [CrossRef] [PubMed]
  33. Qian, L.; Wang, H.; Yang, J.; Chen, X.; Chang, X.; Nan, Y.; He, Z.; Hu, P.; Wu, W.; Liu, T. Amino Acid Cross-Linked Graphene Oxide Membranes for Metal Ions Permeation, Insertion and Antibacterial Properties. Membranes 2020, 10, 296. [Google Scholar] [CrossRef] [PubMed]
  34. Lichawska, M.E.; Kufelnicki, A.; Woźniczka, M. Interaction of microcrystalline chitosan with graphene oxide (GO) and magnesium ions in aqueous solution. BMC Chem. 2019, 13, 57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Ruiz, S.; Tamayo, J.A.; Ospina, J.D.; Navia Porras, D.P.; Valencia Zapata, M.E.; Hernandez, J.H.M.; Valencia, C.H.; Zuluaga, F.; Grande Tovar, C.D. Antimicrobial Films Based on Nanocomposites of Chitosan/Poly(vinyl alcohol)/Graphene Oxide for Biomedical Applications. Biomolecules 2019, 9, 109. [Google Scholar] [CrossRef] [Green Version]
  36. Valencia, C.; Valencia, C.H.; Zuluaga, F.; Valencia, M.E.; Mina, J.H.; Grande-Tovar, C.D. Synthesis and Application of Scaffolds of Chitosan-Graphene Oxide by the Freeze-Drying Method for Tissue Regeneration. Molecules 2018, 23, 2651. [Google Scholar] [CrossRef] [Green Version]
  37. Nikkhah, S.; Tahermansouri, H.; Chekin, F. Synthesis, characterization, and electrochemical properties of the modified graphene oxide with 4,4′-methylenedianiline. Mater. Lett. 2018, 211, 323–327. [Google Scholar] [CrossRef]
  38. Saleem, H.; Haneef, M.; Abbasi, H.Y. Synthesis route of reduced graphene oxide via thermal reduction of chemically exfoliated graphene oxide. Mater. Chem. Phys. 2018, 204, 1–7. [Google Scholar] [CrossRef]
  39. Assal, M.E.; Shaik, M.R.; Kuniyil, M.; Khan, M.; Al-Warthan, A.; Siddiqui, M.R.H.; Khan, S.M.A.; Tremel, W.; Tahir, M.N.; Adil, S.F. A highly reduced graphene oxide/ZrOx–MnCO3 or –Mn2O3 nanocomposite as an efficient catalyst for selective aerial oxidation of benzylic alcohols. RSC Adv. 2017, 7, 55336–55349. [Google Scholar] [CrossRef] [Green Version]
  40. Aliyev, E.; Filiz, V.; Khan, M.M.; Lee, Y.J.; Abetz, C.; Abetz, V. Structural Characterization of Graphene Oxide: Surface Functional Groups and Fractionated Oxidative Debris. Nanomaterials 2019, 9, 1180. [Google Scholar] [CrossRef] [Green Version]
  41. Hernández-González, A.C.; Téllez-Jurado, L.; Rodríguez-Lorenzo, L.M. Alginate hydrogels for bone tissue engineering, from injectables to bioprinting: A review. Carbohydr. Polym. 2020, 229, 115514. [Google Scholar] [CrossRef] [PubMed]
  42. Fernando, I.P.S.; Lee, W.; Han, E.J.; Ahn, G. Alginate-based nanomaterials: Fabrication techniques, properties, and applications. Chem. Eng. J. 2020, 391, 123823. [Google Scholar] [CrossRef]
  43. Zheng, H.; Yang, J.; Han, S. The synthesis and characteristics of sodium alginate/graphene oxide composite films crosslinked with multivalent cations. J. Appl. Polym. Sci. 2016, 133, 43616. [Google Scholar] [CrossRef]
  44. Yang, X.; Zhou, T.; Ren, B.; Hursthouse, A.; Zhang, Y. Removal of Mn (II) by Sodium Alginate/Graphene Oxide Composite Double-Network Hydrogel Beads from Aqueous Solutions. Sci. Rep. 2018, 8, 10717. [Google Scholar] [CrossRef] [Green Version]
  45. Liu, S.; Li, L. Effect of functionalized graphene oxide on gelation and scaling law of alginate in aqueous solution. Eur. Polym. J. 2017, 95, 462–473. [Google Scholar] [CrossRef]
  46. Dimiev, A.M.; Tour, J.M. Mechanism of Graphene Oxide Formation. ACS Nano 2014, 8, 3060–3068. [Google Scholar] [CrossRef] [PubMed]
  47. Dimiev, A.M.; Shukhina, K.; Khannanov, A. Mechanism of the graphene oxide formation: The role of water, “reversibility” of the oxidation, and mobility of the C–O bonds. Carbon 2020, 166, 1–14. [Google Scholar] [CrossRef]
  48. Dimiev, A.; Kosynkin, D.V.; Alemany, L.B.; Chaguine, P.; Tour, J.M. Pristine Graphite Oxide. J. Am. Chem. Soc. 2012, 134, 2815–2822. [Google Scholar] [CrossRef]
  49. Yu, H.; Zhang, B.; Bulin, C.; Li, R.; Xing, R. High-efficient Synthesis of Graphene Oxide Based on Improved Hummers Method. Sci. Rep. 2016, 6, 36143. [Google Scholar] [CrossRef] [Green Version]
  50. Bialik-Wąs, K.; Królicka, E.; Malina, D. Impact of the Type of Crosslinking Agents on the Properties of Modified Sodium Alginate/Poly(vinyl Alcohol) Hydrogels. Molecules 2021, 26, 2381. [Google Scholar] [CrossRef]
  51. Abasalizadeh, F.; Moghaddam, S.V.; Alizadeh, E.; Akbari, E.; Kashani, E.; Fazljou, S.M.B.; Torbati, M.; Akbarzadeh, A. Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting. J. Biol. Eng. 2020, 14, 8. [Google Scholar] [CrossRef] [PubMed]
  52. Kühn, P.T.; Meijer, T.L.; Schiavon, I.; van Poll, M.; van Aken, J.; Groen, S.; Kuijer, R.; van Kooten, T.G.; van Rijn, P. Non-Covalently Stabilized Alginate Hydrogels as Functional Cell Scaffold Material. Macromol. Biosci. 2016, 16, 1693–1702. [Google Scholar] [CrossRef] [PubMed]
  53. Zhuang, Y.; Yu, F.; Chen, H.; Zheng, J.; Ma, J.; Chen, J. Alginate/graphene double-network nanocomposite hydrogel beads with low-swelling, enhanced mechanical properties, and enhanced adsorption capacity. J. Mater. Chem. 2016, 4, 10885–10892. [Google Scholar] [CrossRef] [Green Version]
  54. Zhuang, Y.; Yu, F.; Chen, J.; Ma, J. Batch and column adsorption of methylene blue by graphene/alginate nanocomposite: Comparison of single-network and double-network hydrogels. J. Environ. Chem. Eng. 2016, 4, 147–156. [Google Scholar] [CrossRef]
  55. Duong, H.T.T.; Thambi, T.; Yin, Y.; Kim, S.H.; Nguyen, T.L.; Giang Phan, V.H.; Kim, J.; Jeong, J.H.; Lee, D.S. Degradation-regulated architecture of injectable smart hydrogels enhances humoral immune response and potentiates antitumor activity in human lung carcinoma. Biomaterials 2020, 230, 119599. [Google Scholar] [CrossRef] [PubMed]
  56. Giang Phan, V.H.; Murugesan, M.; Manivasagan, P.; Nguyen, T.L.; Phan, T.-H.; Luu, C.H.; Ho, D.-K.; Li, Y.; Kim, J.; Lee, D.S.; et al. Injectable Hydrogel Based on Protein-Polyester Microporous Network as an Implantable Niche for Active Cell Recruitment. Pharmaceutics 2022, 14, 709. [Google Scholar] [CrossRef]
Gels 08 00246 sch001 550
Scheme 1. Illustrative models of GO-SA hydrogel physically crosslinked by divalent Ca2+ cations for LH delivery.
Scheme 1. Illustrative models of GO-SA hydrogel physically crosslinked by divalent Ca2+ cations for LH delivery.
Gels 08 00246 sch001
Gels 08 00246 g001 550
Figure 1. (A) Fourier-transform infrared (FTIR) spectra and (B) Thermogravimetric analysis of GO2 (red line), GO4 (blue line), GO6 (black line) and graphite (square dotted line); (C,D) Scanning electron microscopic (SEM) images of GO6 dispersed in deionized water solution.
Figure 1. (A) Fourier-transform infrared (FTIR) spectra and (B) Thermogravimetric analysis of GO2 (red line), GO4 (blue line), GO6 (black line) and graphite (square dotted line); (C,D) Scanning electron microscopic (SEM) images of GO6 dispersed in deionized water solution.
Gels 08 00246 g001
Gels 08 00246 g002 550
Figure 2. (A) Solubility of graphite and GOs after 12 h dispersed in deionized water. (B) Solubility of GO6 after 12 h dispersed in surfactant and salt. (C) Investigation of ion complexes formulation of graphene oxide and lidocaine hydrochloride.
Figure 2. (A) Solubility of graphite and GOs after 12 h dispersed in deionized water. (B) Solubility of GO6 after 12 h dispersed in surfactant and salt. (C) Investigation of ion complexes formulation of graphene oxide and lidocaine hydrochloride.
Gels 08 00246 g002
Gels 08 00246 g003 550
Figure 3. (A) Macroscopic images of hydrogel development. The experiment was conducted with blank SA hydrogel and GO-SA hydrogel. Both hydrogel systems commenced forming hydrogel at the feeding concentration of crosslinker of 0.04 mol/L, which zoning within a dotted area. SEM images of (B) SA and (C) GO-SA hydrogels.
Figure 3. (A) Macroscopic images of hydrogel development. The experiment was conducted with blank SA hydrogel and GO-SA hydrogel. Both hydrogel systems commenced forming hydrogel at the feeding concentration of crosslinker of 0.04 mol/L, which zoning within a dotted area. SEM images of (B) SA and (C) GO-SA hydrogels.
Gels 08 00246 g003
Gels 08 00246 g004 550
Figure 4. Degradation of SA and GO-SA hydrogels in PBS.
Figure 4. Degradation of SA and GO-SA hydrogels in PBS.
Gels 08 00246 g004
Gels 08 00246 g005 550
Figure 5. The in vitro lidocaine hydrochloride release profiles of SA and GO-SA systems in PBS solution. The error bars in the graph represent standard deviations (n = 4).
Figure 5. The in vitro lidocaine hydrochloride release profiles of SA and GO-SA systems in PBS solution. The error bars in the graph represent standard deviations (n = 4).
Gels 08 00246 g005
Gels 08 00246 g006 550
Figure 6. The in vitro cell viability of L929 mouse fibroblast cells exposed with different concentration of SA and GO-SA hydrogels. The error bars in the graph represent standard deviations (n = 4).
Figure 6. The in vitro cell viability of L929 mouse fibroblast cells exposed with different concentration of SA and GO-SA hydrogels. The error bars in the graph represent standard deviations (n = 4).
Gels 08 00246 g006
Gels 08 00246 g007 550
Figure 7. Photographs of the in vivo study: (A) Grey bumps of GO-SA hydrogel cured under the mice’s skin after hypodermic injection, (B) Incision to test stable gel formation of the hydrogel. (C) After a week, the hydrogel remained stable without inflammation and (D) After 1 week, disintegration of the GO-SA hydrogels was observed. This is mainly due to the slow exchange of cations and salt effects.
Figure 7. Photographs of the in vivo study: (A) Grey bumps of GO-SA hydrogel cured under the mice’s skin after hypodermic injection, (B) Incision to test stable gel formation of the hydrogel. (C) After a week, the hydrogel remained stable without inflammation and (D) After 1 week, disintegration of the GO-SA hydrogels was observed. This is mainly due to the slow exchange of cations and salt effects.
Gels 08 00246 g007
Table
Table 1. Gelation time of GO-free and GO-integrated SA hydrogels. Gelation time recorded in seconds.
Table 1. Gelation time of GO-free and GO-integrated SA hydrogels. Gelation time recorded in seconds.
Ca2+ Concentration (mol/L)
0.010.020.030.040.050.060.07
SA gel (s)No gel formation71.7 ± 1.565.3 ± 1.249.0 ± 1.032.7 ± 2.1
GO-SA gel (s)No gel formation61.7 ± 0.652.3 ± 0.641.7 ± 1.230.3 ± 1.5
Table
Table 2. The compositions of hydrogel samples before testing aqueous degradation.
Table 2. The compositions of hydrogel samples before testing aqueous degradation.
Sample NoGO6 (mL)SA 8% (mL)LH 2% (mL)Ca2+ (0.06M) (mL)PBS (mL)
GO0-SA0.5 (0%)0.50.50.53.0
GO0.125-SA0.5 (0.125%)0.50.50.53.0
GO0.250-SA0.5 (0.250%)0.50.50.53.0
GO0.500-SA0.5 (0.500%)0.50.50.53.0
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Luu, C.H.; Nguyen, G.; Le, T.-T.; Nguyen, T.-M.N.; Giang Phan, V.H.; Murugesan, M.; Mathiyalagan, R.; Jing, L.; Janarthanan, G.; Yang, D.C.; et al. Graphene Oxide-Reinforced Alginate Hydrogel for Controlled Release of Local Anesthetics: Synthesis, Characterization, and Release Studies. Gels 2022, 8, 246. https://doi.org/10.3390/gels8040246

AMA Style

Luu CH, Nguyen G, Le T-T, Nguyen T-MN, Giang Phan VH, Murugesan M, Mathiyalagan R, Jing L, Janarthanan G, Yang DC, et al. Graphene Oxide-Reinforced Alginate Hydrogel for Controlled Release of Local Anesthetics: Synthesis, Characterization, and Release Studies. Gels. 2022; 8(4):246. https://doi.org/10.3390/gels8040246

Chicago/Turabian Style

Luu, Cuong Hung, Giang Nguyen, Thanh-Tuyen Le, Thanh-Mai Ngoc Nguyen, V. H. Giang Phan, Mohanapriya Murugesan, Ramya Mathiyalagan, Lu Jing, Gopinathan Janarthanan, Deok Chun Yang, and et al. 2022. "Graphene Oxide-Reinforced Alginate Hydrogel for Controlled Release of Local Anesthetics: Synthesis, Characterization, and Release Studies" Gels 8, no. 4: 246. https://doi.org/10.3390/gels8040246

APA Style

Luu, C. H., Nguyen, G., Le, T. -T., Nguyen, T. -M. N., Giang Phan, V. H., Murugesan, M., Mathiyalagan, R., Jing, L., Janarthanan, G., Yang, D. C., Li, Y., & Thambi, T. (2022). Graphene Oxide-Reinforced Alginate Hydrogel for Controlled Release of Local Anesthetics: Synthesis, Characterization, and Release Studies. Gels, 8(4), 246. https://doi.org/10.3390/gels8040246

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop